MK2 is a therapeutic target for high-risk multiple myeloma

Title
MK2 is a therapeutic target for high-risk multiple myeloma
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume -, Issue -, Pages haematol.2017.182121
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2018-03-22
DOI
10.3324/haematol.2017.182121

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now